Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,823 | -34,045 | -15,334 | -69,776 | -54,892 |
| Depreciation Amortization | 354 | 298 | 183 | 925 | 697 |
| Other Working Capital | 4,330 | 1,900 | -902 | -11,199 | -7,948 |
| Other Operating Activity | 4,850 | 1,439 | -235 | 8,114 | 6,990 |
| Operating Cash Flow | $-40,289 | $-30,408 | $-16,288 | $-71,936 | $-55,153 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47 | 47 | N/A | 9,557 | 244 |
| Other Financing Activity | -484 | -478 | -395 | -46 | -46 |
| Financing Cash Flow | $-437 | $-431 | $-395 | $9,511 | $198 |
| Beginning Cash Position | 49,046 | 49,046 | 49,046 | 111,471 | 111,471 |
| End Cash Position | 8,320 | 18,207 | 32,363 | 49,046 | 56,516 |
| Net Cash Flow | $-40,726 | $-30,839 | $-16,683 | $-62,425 | $-54,955 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,289 | -30,408 | -16,288 | -71,936 | -55,153 |
| Free Cash Flow | -40,289 | -30,408 | -16,288 | -71,936 | -55,153 |